Pages that link to "Q48542036"

The following pages link to Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors (Q48542036):

Displaying 43 items.

• Emerging preclinical pharmacological targets for Parkinson's disease (Q26764724) (← links)
• The role of the Rho/ROCK signaling pathway in inhibiting axonal regeneration in the central nervous system (Q26775044) (← links)
• Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury (Q28270949) (← links)
• Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration (Q33627982) (← links)
• Brain renin-angiotensin system and dopaminergic cell vulnerability (Q33861951) (← links)
• LIM kinase-2 induces programmed necrotic neuronal death via dysfunction of DRP1-mediated mitochondrial fission (Q34393738) (← links)
• The role of Galectin-3 in α-synuclein-induced microglial activation (Q34537231) (← links)
• Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectives (Q35187475) (← links)
• Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34 (Q35949121) (← links)
• Endothelin-1 induces LIMK2-mediated programmed necrotic neuronal death independent of NOS activity (Q36127043) (← links)
• Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders (Q36148314) (← links)
• Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system (Q36162933) (← links)
• The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia. (Q36222798) (← links)
• Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease (Q36576487) (← links)
• Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease (Q36825541) (← links)
• Bidirectional neuro-glial signaling modalities in the hypothalamus: role in neurohumoral regulation (Q36882293) (← links)
• Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease. (Q36930483) (← links)
• Glial-mediated inflammation underlying parkinsonism (Q37287778) (← links)
• Rho kinase II interference by small hairpin RNA ameliorates 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine‑induced parkinsonism in mice (Q37707773) (← links)
• Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? (Q38086608) (← links)
• Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system (Q38100285) (← links)
• Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. (Q38127396) (← links)
• Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins. (Q38190099) (← links)
• Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease (Q38260925) (← links)
• Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders. (Q38530085) (← links)
• Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis (Q38728605) (← links)
• Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation (Q38942116) (← links)
• Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration. (Q38969930) (← links)
• Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin. (Q39055955) (← links)
• Altered Expression of Growth Associated Protein-43 and Rho Kinase in Human Patients with Parkinson's Disease (Q40126181) (← links)
• Discovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin (Q41464226) (← links)
• Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update (Q43679571) (← links)
• Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease (Q46316918) (← links)
• Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway (Q46522841) (← links)
• Aging-related Increase in Rho Kinase Activity in the Nigral Region Is Counteracted by Physical Exercise. (Q48722360) (← links)
• Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model (Q50912852) (← links)
• Upregulation of Gem relates to retinal ganglion cells apoptosis after optic nerve crush in adult rats. (Q55073618) (← links)
• Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities. (Q55644124) (← links)
• Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death (Q64865922) (← links)
• Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide (Q89548582) (← links)
• ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson's disease (Q90440777) (← links)
• Rho-associated coiled-coil kinase 1 activation mediates amyloid precursor protein site-specific Ser655 phosphorylation and triggers amyloid pathology (Q91740761) (← links)
• The protective effect of the Rho-kinase inhibitor hydroxyfasudil on propofol-induced hippocampal neuron apoptosis in neonatal rats (Q92715920) (← links)